• Rotavirus Infection Suppresses Nrf2-Mediated Redox Defense P

  2026-07-03

  This study reveals that progressive rotavirus infection leads to a robust downregulation of the redox-sensitive transcription factor Nrf2 and its cytoprotective gene network in host cells. These findings expose a critical vulnerability in the host’s antioxidant defense during viral infection and offer mechanistic insights for designing experiments that target redox and ER stress pathways.

• PNU 74654: Precision Wnt/β-Catenin Inhibition in Muscle Rege

  2026-07-02

  Explore how PNU 74654, a potent Wnt signaling pathway inhibitor, enables advanced mechanistic dissection of muscle regeneration and adipogenesis. This article delivers deep scientific insight and actionable strategies for researchers targeting cell proliferation and differentiation.

• Quercetin as a PI3K Inhibitor: Protocols for Liver & Cancer

  2026-07-02

  Quercetin stands out among PI3K inhibitors for its dual ability to block tumor growth and suppress ferroptosis-mediated liver injury. This guide translates recent evidence and APExBIO’s application insights into actionable workflows, troubleshooting, and advanced use-cases to accelerate translational research.

• Polymeric Vectors for Stable and Efficient Firefly Luciferas

  2026-07-01

  This study introduces a rational design strategy for polymeric mRNA delivery vectors that achieve both room-temperature storage stability and high delivery efficiency. The work details a '4Q' principle to optimize vector performance and demonstrates superior reporter gene expression compared to current nonviral systems, with implications for advancing mRNA-based research and therapeutic development.

• Omeprazole (A2845): Technical Guide for Gastric Acid Researc

  2026-07-01

  Omeprazole (SKU A2845) is a well-characterized, potent H+,K+-ATPase inhibitor designed for controlled research on gastric acid secretion and antiulcer mechanisms. It is best suited for in vitro and in vivo mechanistic studies with rigorous protocol adherence and should not be used for diagnostic or clinical applications.

• CK2 and ERK8 Inhibition: Shaping the Future of Phase Separat

  2026-06-30

  This thought-leadership article explores how the selective inhibition of CK2 and ERK8 by 2-(4,5,6,7-tetrabromo-2-(dimethylamino)-1H-benzo[d]imidazol-1-yl)acetic acid unlocks new opportunities in the study of protein phase separation, kinase-driven signaling, and translational biochemistry. Mechanistic insights, competitive advantage, and strategic recommendations are presented for researchers seeking to advance molecular toolkits and experimental workflows. The discussion is anchored in recent breakthroughs on viral condensate biology and highlights APExBIO's leadership in providing reliable research-use-only chemicals.

• Advancing Apoptosis Assays: Mechanistic Precision for Transl

  2026-06-30

  Explore how the Caspase-3 Fluorometric Assay Kit empowers researchers to dissect apoptosis with mechanistic clarity, validated by recent RCC findings and benchmarked against evolving translational needs. This article provides a strategic framework for integrating quantitative caspase-3 activity detection into oncology, neurodegeneration, and beyond, while critically appraising competitive solutions and addressing the translational significance of robust cysteine-dependent aspartate-directed protease assays.

• Isoliensinine Modulates TRPV1–AMPK Pathway to Counter Liver

  2026-06-29

  This study demonstrates that isoliensinine from Plumula Nelumbinis attenuates hepatic fibrosis in metabolic associated fatty liver disease (MAFLD) by restoring lipid droplet metabolism via the TRPV1–AMPK signaling axis. The findings bridge dietary natural product pharmacology and mechanistic insights into energy metabolism regulation, highlighting translational opportunities for fibrosis intervention.

• IWR-1-endo: Wnt Signaling Inhibitor for Advanced Cancer Mode

  2026-06-29

  IWR-1-endo stands out as a potent Wnt signaling inhibitor, uniquely enabling precise modulation of the Wnt/β-catenin pathway in both cancer and regenerative models. This guide translates core research findings into hands-on workflows, troubleshooting strategies, and actionable protocol upgrades for the modern cell biology lab.

• Batimastat (BB-94): Potent MMP Inhibitor for Cancer & Synaps

  2026-06-28

  Batimastat (BB-94) is a nanomolar-potency matrix metalloproteinase (MMP) inhibitor with demonstrated efficacy in tumor growth and angiogenesis inhibition. Its hydroxamate-based mechanism allows broad-spectrum action in both cancer and neuromuscular research, as confirmed by in vitro and in vivo benchmarks. APExBIO supplies Batimastat for research use, supporting robust experimental workflows.

• Shionone Activates Mitophagy to Ameliorate Pulmonary Fibrosi

  2026-06-27

  This study demonstrates that shionone alleviates pulmonary fibrosis by activating PINK1-Parkin-mediated mitophagy, leading to enhanced clearance of dysfunctional mitochondria and reduced oxidative stress. These findings identify a new anti-fibrotic mechanism with translational potential and highlight the importance of precise ROS measurement in mechanistic studies.

• Antidepressant Effects of Rotigotine in Experimental Models

  2026-06-26

  This study explores the antidepressant properties of rotigotine, a dopamine D2/D3 receptor agonist, in validated animal models of depression. Findings indicate rotigotine reverses behavioral deficits linked to depression at specific doses, suggesting a potential for modulating dopaminergic pathways beyond motor symptom control.

• Concanavalin A Targets Conserved N-Glycans for Coronavirus I

  2026-06-26

  Guo et al. have demonstrated that concanavalin A (ConA) binds phylogenetically conserved N-linked glycans on coronavirus spike proteins, broadly inhibiting viral entry and membrane fusion. This work highlights conserved glycosylation as a stable vulnerability, informing the development of broad-spectrum antivirals and advancing glycan-targeted virology research.

• Nadolol (SQ-11725) in Hypertension Research: Workflow & PK I

  2026-06-25

  Nadolol (SQ-11725) empowers cardiovascular and vascular headache research with its robust beta-adrenergic blockade and unique OATP1A2 transporter profile. This guide delivers actionable workflow enhancements, protocol parameters, and troubleshooting strategies, translating novel pharmacokinetic insights into practical, reproducible experiments.

• WEHI-539 in Functional Apoptosis Mapping: Beyond Cancer Mode

  2026-06-25

  Explore how WEHI-539, a selective BCL-XL inhibitor, enables functional mapping of apoptosis beyond standard cancer models. This article delivers unique mechanistic insights and practical protocol guidance to advance apoptosis research.

458 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page